Order Permitting Emergency Dispensing of Oral Formulations of Doxycycline and Waiver of CGMP Requirements during an Anthrax Emergency

This order allows public health emergency stakeholders to permit emergency dispensing of FDA-approved oral dosage forms of doxycycline products without prescription for the post-exposure treatment of “inhalational anthrax during an emergency involving Bacillus anthracis (B. anthracis), the biological agent that causes anthrax disease.”